Bliss GVS Pharma Limited — Others, 07-11-2024: Action(s) taken or orders passed

Bliss GVS Pharma Limited received an Audit Observation Letter from the Central GST authority, confirming a tax liability of ₹8,71,814, alongside ₹4,45,888 in interest and a penalty of ₹99,193. The liabilities pertain to the fiscal years 2018-19 to 2022-23, due to discrepancies in Input Tax Credit reporting and non-payment of GST on foreign bank charges. This may have significant financial implications for the company.